FBN1 and congenital heart disease: The detection of FBN1 point mutations in patients with BAV with aortic dilatation/aneurysm but without MFS adds to the striking clinical heterogeneity of type I fibrillinopathies to include a small number of patients bearing the most common congenital heart disease.